Delivery Order SPE2DB22D1041-SPE2DB25FUBV1
Award Date 9/5/25
Potential Completion Date 9/8/25
Potential Value $5.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at approximately $25.5K to AmerisourceBergen Drug Corp for Xeljanz XR 11 mg tablets on August 28, 2025, with an ultimate completion date of August 29, 2025. This is a firm fixed-price contract with no set-aside designation, indicating competitive award. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. Xeljanz XR is a branded immunosuppressant medication used to treat...
- The Defense Logistics Agency awarded a delivery order valued at $19,871.35 to AmerisourceBergen Drug Corp for the supply of Xeljanz 5 mg tablets (60-count units) on October 29, 2025, with an ultimate completion date of October 30, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Xeljanz is a prescription immunosuppressant medication used to treat...
- The Defense Logistics Agency awarded a delivery order valued at $9,572.59 to AmerisourceBergen Drug Corp for the supply of Xeljanz XR 11 mg tablets (30-count units). This firm fixed price contract, awarded on June 4, 2025, with an ultimate completion date of June 5, 2025, represents a non-competitive procurement without set-aside provisions. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a competitive firm fixed-price delivery order to AmerisourceBergen Drug Corp for $4,510.98 to supply Xeljanz XR 11 mg tablets in 30-count units. This non-set-aside contract was awarded on September 12, 2025, with an ultimate completion date of September 15, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Xeljanz XR is a pharmaceutical product used in the treatment of rheumatoid arthritis and other...
- The Defense Logistics Agency (DLA) awarded a $7,570.74 delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Xeljanz XR 11 mg tablets (30-count units). This competitively awarded, firm fixed-price contract contains no set-aside designation and requires completion by November 6, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. Xeljanz XR is a prescription medication used primarily for rheumatoid arthritis and other inflammatory...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $5,034.64 to supply Xeljanz XR 11 mg tablets (30-count units) with a completion date of October 24, 2025. This competitive, non-set-aside award utilizes firm fixed pricing and represents a single delivery order under a larger contract vehicle. The pharmaceutical will be delivered to the vendor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a...
- The Defense Logistics Agency awarded a delivery order valued at $41,025.98 to AmerisourceBergen Drug Corp for XELJANZ XR 11 MG tablets (30-count units) on November 4, 2025, with an ultimate completion date of November 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. XELJANZ XR is a prescription medication used to treat rheumatoid arthritis and...
- The Defense Logistics Agency awarded a delivery order valued at $4,519.47 to AmerisourceBergen Drug Corp for the supply of Xeljanz 5 mg tablets (60-count units) on September 3, 2025, with an ultimate completion date of September 4, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Xeljanz is a prescription immunosuppressant medication used to treat rheumatoid...
- The Defense Logistics Agency awarded a $5,031.72 delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Xeljanz XR 11 mg tablets (30-count unit dose packaging). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 26, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $14,401.37 to AmerisourceBergen Drug Corp for XELJANZ XR 11 mg tablets (30-count units) on June 26, 2025, with completion scheduled for June 27, 2025. This firm fixed-price delivery order represents a non-competitive set-aside transaction and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. XELJANZ XR is a prescription immunosuppressant medication used to treat rheumatoid arthritis and...